ADVA
14.12.2020 09:02:08 CET | Business Wire | Press release
ADVA (FSE: ADV) today announced the continuing expansion of its Ensemble Harmony Ecosystem . With the addition of 20 members, the industry’s leading network functions virtualization (NFV) partner program features an even broader range of virtualized applications and supported services. New additions to the multi-vendor ecosystem include cloud, virtualization, networking and security leader, VMware. Communication service providers (CSPs) can now benefit from open solutions developed by over 65 members, including more than 50 virtual network functions (VNFs) and more than 40 white box servers.
“We’re excited to be joining the Ensemble Harmony Ecosystem, helping it accelerate the pace of NFV innovation and generate new value for our customers. This program is key to creating the openness and interoperability needed in the new age of software-based telecommunication networks,” said Mark Vondemkamp, VP, Products, SD-WAN and SASE Business, VMware. “For us, the Ensemble Harmony Ecosystem enables comprehensive virtualized solutions. It enables CSPs to choose from a wide variety of commercial VNFs and effortlessly realize the promise of NFV. Ensemble Harmony also makes it easy for us to deliver a consistent cloud architecture all the way from the public cloud to the network edge.”
ADVA’s Ensemble Harmony Ecosystem is a coalition of hardware, software and service partners working together to drive virtualization and softwarization in telecommunication networks. The program delivers everything CSPs require to harness the full benefits of NFV and automation. It fosters close collaboration between partners to ensure interoperability and provides the ability to select from industry-leading solutions, including the most popular SD-WAN, firewall and WAN optimization products. Aside from VMware, the most recent additions to the Ensemble Harmony Ecosystem are CASwell, flexiWAN, IEI Integration Corp, NEXCOM and Lanner.
“Lanner continues to work with ADVA on CSP adoption of NFV. And our support and promotion of Ensemble Harmony is another great example of how we together provide solutions that outperform purpose-built platforms in every way,” said Sven Freudenfeld, CTO, Lanner Inc. “Lanner’s Whitebox Solutions™, coupled with Ensemble and VNF partners, provide solutions that are available off-the-shelf, with the best technology, pre-validated, and fully homologated.”
“This ongoing growth means our Ensemble Harmony Ecosystem provides more options and delivers more value. By welcoming industry leaders like VMware into the program, we’re enabling our customers to transform their operations with some of the best available cloud solutions,” commented James Buchanan, GM, Edge Cloud, ADVA. “Today’s CSPs demand the freedom to choose the most advanced virtualization technology from a variety of leading innovators. They expect tech suppliers to cooperate with each other to ensure interoperability and reduce complexity. That’s what our Ensemble Harmony Ecosystem is all about. It creates an environment that fosters close cooperation, accelerates new initiatives and enables true multi-vendor solutions.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com
.
Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com
VMware, and VMware SD-WAN are registered trademarks or trademarks of VMware, Inc. in the United States and other jurisdictions. All other marks and names mentioned herein may be trademarks of their respective companies.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005045/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sharjah Ruler Receives Portugal’s Grand Collar of Order of Camões31.1.2026 18:27:00 CET | Press release
His Excellency Marcelo Rebelo de Sousa, President of the Portuguese Republic, awarded His Highness Sheikh Dr Sultan bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah, the Grand Collar of the Order of Camões (Grande Colar da Ordem de Camões), the highest sovereign cultural order in Portugal. His Highness is the first Arab figure to receive the Order of Camões and the sixth recipient worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260131119526/en/ Sharjah Ruler receives Portugal’s Grand Collar of Order of Camões (Photo: AETOSWire) The honour was conferred during a ceremony hosted by the Portuguese President at the Presidential Palace in Lisbon. The event was attended by Sheikha Bodour bint Sultan Al Qasimi, Chairperson of the Sharjah Book Authority, alongside senior officials. The ceremony recognised His Highness’s prominent global stature, as a leading figure in culture, intellectual thought and in
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release
Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom